C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2006
11/08/2006	CN1859907A Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/08/2006	CN1283640C Ramification in albocarbon category and application in anoxia system
11/08/2006	CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006	CN1283629C Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compsns. and dyeing methods
11/07/2006	US7132543 Para-phenylenediamine derivatives containing a disubstituted pyrrolidinyl group bearing a cationic radical, and use of the same for dyeing keratin fibers
11/07/2006	US7132539 Melanocortin receptor ligands
11/07/2006	US7132534 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132437 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	US7132421 Antiproliferative agnets
11/07/2006	US7132419 Benzo[a]phenazine-11-carboxamide derivative used as fungicide, bactericide, inhibitors of topoisomerase for treating cancer
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132414 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2186023C Process for preparing 2-piperazine carboxylic acid derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006	WO2006116157A2 Dipeptidyl peptidase-iv inhibitors
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006	WO2006114581A1 A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles
11/02/2006	WO2006114575A1 Novel development accelerator-releasing couplers
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114221A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006	WO2006084854A3 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	US20060247442 Process for preparing isatins with control of side-product formation
11/02/2006	US20060247441 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/02/2006	US20060247440 Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
11/02/2006	US20060247437 Preparation of ketone amides
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247278 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
11/02/2006	US20060247277 Polymorphs of s-omeprazole
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247263 Substituted heterocyclic compounds and methods of use
11/02/2006	US20060247262 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247254 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity
11/02/2006	US20060247250 Pyrimidine inhibitors of kinases
11/02/2006	US20060247247 Pyrazole-amine compounds useful as kinase inhibitors
11/02/2006	US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006	US20060247242 Pesticidal compositions
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247239 Melanin concentrating hormone antagonists
11/02/2006	US20060247232 Heterocyclic compound and antitumor agent containing the same as effective ingredient
11/02/2006	US20060247230 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247227 Substituted piperidines as histamine h3 receptor ligands
11/02/2006	US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060246524 Nanoparticle conjugates
11/02/2006	US20060246023 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717228A1 Sulfonylamino(thio)carbonylderivatives as herbicides or plant growth regulators
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717221A1 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716151A1 Compositions useful as inhibitors of protein kinases
11/02/2006	EP1716139A1 Olmesartan medoxomil with reduced levels of impurities
11/02/2006	EP1716138A1 Process for preparing olmesartan medoxomil at ph higher than 2.5
11/02/2006	EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
11/02/2006	EP1716124A1 Maleimide resin with cyanurate core
11/02/2006	EP1716123A1 Pyridazinone derivatives and their use as pde4 inhibitors
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006	EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006	EP1399117B1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1377278B1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	CA2606268A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006	CA2605453A1 Novel benzimidazole compounds having crf antagonistic activity and pharmaceutical compositions containing them
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
10/2006
10/31/2006	US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006	US7129253 Compounds
10/31/2006	US7129250 Neuroprotective and anti-proliferative compounds
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129233 Competitive and selective inhibitors of trypsin-like serine proteases involved in hemostasis; anticoagulants; e.g., 1-((1-haloalkoxy)phenyl)-),2-(hydroxy),ethyl)carbonyl-),2-((4-amidinopyrid-1-yl)methaminocarbonyl)pyrrole

1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 626